BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33762574)

  • 21. LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway.
    Xu R; Zhang Y; Li A; Ma Y; Cai W; Song L; Xie Y; Zhou S; Cao W; Tang X
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway.
    Zhong C; Chen Y; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    BMC Cancer; 2018 Jul; 18(1):722. PubMed ID: 29980193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia Induced by Cobalt Chloride Triggers Autophagic Apoptosis of Human and Mouse Drug-Resistant Glioblastoma Cells through Targeting the PI3K-AKT-mTOR Signaling Pathway.
    Lee YW; Cherng YG; Yang ST; Liu SH; Chen TL; Chen RM
    Oxid Med Cell Longev; 2021; 2021():5558618. PubMed ID: 34136065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.
    Schöning JP; Monteiro M; Gu W
    Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):153-161. PubMed ID: 27809360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1α/Akt axis in glioblastoma.
    Inukai M; Hara A; Yasui Y; Kumabe T; Matsumoto T; Saegusa M
    Hum Pathol; 2015 Oct; 46(10):1496-505. PubMed ID: 26256949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of HIF1α- and HIF2α-regulated BNIP3 in hypoxia-induced injury of neurons.
    Zhu L; Qi B; Hou D
    Pathol Res Pract; 2019 Apr; 215(4):822-827. PubMed ID: 30704780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells.
    Chiavarina B; Martinez-Outschoorn UE; Whitaker-Menezes D; Howell A; Tanowitz HB; Pestell RG; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Sep; 11(17):3280-9. PubMed ID: 22894905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIF-1α promotes inflammatory response of chronic obstructive pulmonary disease by activating EGFR/PI3K/AKT pathway.
    Zhang HX; Yang JJ; Zhang SA; Zhang SM; Wang JX; Xu ZY; Lin RY
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6077-6084. PubMed ID: 30280794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
    Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
    Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
    Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T; Cui L; Wang H; Wang H; Han N
    J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
    Cheng Y; Xie P
    J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors.
    Mao XG; Yan M; Xue XY; Zhang X; Ren HG; Guo G; Wang P; Zhang W; Huo JL
    Lab Invest; 2011 Jul; 91(7):1068-78. PubMed ID: 21483406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma.
    Mohapatra SR; Sadik A; Tykocinski LO; Dietze J; Poschet G; Heiland I; Opitz CA
    Front Immunol; 2019; 10():2762. PubMed ID: 31866995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway.
    Mu Q; Wang L; Yu F; Gao H; Lei T; Li P; Liu P; Zheng X; Hu X; Chen Y; Jiang Z; Sayari AJ; Shen J; Huang H
    Cancer Biol Ther; 2015; 16(4):623-33. PubMed ID: 25719943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.